We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a cost effectiveness analysis to evaluate your digital health product.
As part of Dstl's commitment to improving access to technologies, we're making some of our intellectual property (IP) available for free.
Guidance for infrastructure operators and motor vehicle manufacturers and dealers.
This collection brings together guidance and associated documents relating to alternative pricing
How to use a cost utility analysis to evaluate your digital health product.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Submit HM Land Registry applications in the portal, reducing errors and requisitions.
How to use a randomised controlled trial to evaluate your digital health product.
Compare different evaluation approaches and choose an appropriate method.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).